AMED GoodMoat Verdict
Full signal breakdown coming soon. Use the X-Ray tool for a detailed analysis.
Amedisys Inc
Exchange: NASDAQSector: HealthcareIndustry: Medical Care Facilities
Amedisys, Inc. is a leading healthcare at home company delivering personalized home health, hospice and high-acuity care services. Amedisys is focused on delivering the care that is best for our patients, whether that is inpatient hospital, palliative, and skilled nursing facility (“SNF”) care in their homes; home-based recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life. Nearly 3,000 hospitals and more than 110,000 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an executive office in Nashville, TN, Amedisys is a publicly held company. With approximately 19,000 employees in 521 care centers in 37 states and the District of Columbia, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of nearly 470,000 patients in need every year, performing more than 10.6 million visits annually.
Did you know?
Net income compounded at -15.6% annually over 6 years.
Current Price
$100.99
+0.01%GoodMoat Value
$205.64
103.6% undervaluedProfile
Valuation (TTM)
Market Cap$3.31B
P/E38.71
EV—
P/B2.92
Shares Out32.82M
P/Sales1.38
Revenue$2.40B
EV/EBITDA14.14
Amedisys Inc (AMED) Quality Analysis
AMED Profitability
Profitability trend analysis coming soon
AMED Growth
Growth trend analysis coming soon
AMED Financial Health
Financial health indicators coming soon
AMED Quality & Fundamental Analysis
Amedisys Inc (AMED) is a Healthcare company in the Medical Care Facilities industry, listed on NASDAQ. This quality analysis page evaluates Amedisys Inc's financial health using the Piotroski F-Score methodology, profitability ratios, growth trajectory, and balance sheet strength.
Amedisys Inc has a Piotroski F-Score of N/A out of 9, measuring profitability, leverage, and operating efficiency. The company operates with a profit margin of 3.56% and a return on equity (ROE) of 7.55%. Return on assets (ROA) stands at 4.00%.
The debt-to-equity ratio is 0.40, with a current ratio of 1.23. Operating margin is 4.03%.
GoodMoat's quality analysis uses AI-powered insights to evaluate whether Amedisys Inc is a fundamentally sound investment. The GoodMoat Verdict synthesizes profitability, growth, and financial health scores into a clear investment quality rating. Use these metrics alongside valuation tools like the DCF calculator and fair value models to make informed investment decisions.